BL
CMD

Balentine LLC’s Cantel Medical Corporation CMD Stock Holding History

Balentine LLC’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-45
Closed -$5K – 574
2017
Q4 		$5K Hold
45
– – ﹤0.01% 527
2017
Q3 		$4K Hold
45
– – ﹤0.01% 554
2017
Q2 		$4K Hold
45
– – ﹤0.01% 524
2017
Q1 		$4K Buy
+45
New +$3.58K ﹤0.01% 495

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Balentine LLC's CMD Position: Q1 2018 in Review

Balentine LLC sold out of Cantel Medical Corporation (CMD) in Q1 2018, closing a stake of 45 shares — an estimated $5K sold.

Balentine LLC first reported a position in CMD in Q1 2017 and held it in 4 quarters. The position peaked at $5K in Q4 2017. 270 funds tracked by Wall St. Rank hold CMD as of Q1 2018.

  • Balentine LLC reported no remaining Cantel Medical Corporation position as of Q1 2018 after selling out during the quarter.
  • Balentine LLC sold 45 Cantel Medical Corporation shares in Q1 2018, an estimated $5K.
  • Balentine LLC first reported a position in Cantel Medical Corporation in Q1 2017 and held it in 4 quarters.
  • Balentine LLC's Cantel Medical Corporation position peaked at $5K in Q4 2017.
  • 270 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2018.

Based on Balentine LLC's 13F filing for Q1 2018, filed 16 May 2018.